- Constellation Energy recently signed a landmark long-term agreement for Walmart to purchase emissions-free nuclear power from its Dresden Clean Energy Center in Illinois, while also seeking to extend the operating licenses of its Ginna and Nine Mile Point Unit 1 reactors in New York to 2049.
- The Walmart deal, one of the first US nuclear power purchase agreements with a major retailer, underscores growing corporate demand for carbon-free baseload electricity and supports Constellation’s planned efficiency upgrades that expand Dresden’s output without building new plants.
- We’ll now examine how this first-of-its-kind Walmart nuclear power agreement might reshape Constellation’s investment narrative around long-dated clean contracts.
Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 30 best rare earth metal stocks of the very few that mine this essential strategic resource.
Constellation Energy Investment Narrative Recap
To own Constellation Energy, you need to believe that long-dated, carbon-free power contracts and supportive nuclear policy can offset aging-asset and regulatory cost risks. Near term, the key catalyst is how effectively Constellation converts corporate and AI-driven demand into firm, premium contracts, while the biggest risk remains rising regulatory and lifecycle costs tied to its nuclear fleet. The Walmart Dresden deal reinforces the contract story but does not materially change those underlying risks.
The most relevant recent announcement alongside the Walmart agreement is Constellation’s move to extend the Ginna and Nine Mile Point Unit 1 reactor licenses to 2049. If approved, this would align nuclear asset lives with potential future long-term contracts, supporting the company’s effort to lock in multi-decade, clean baseload deals. It also underscores the ongoing regulatory scrutiny and capital commitments that sit behind Constellation’s clean energy investment case.
Yet even as contracts lengthen and index inclusions grow, investors should still be aware of rising long-term nuclear compliance and decommissioning risks that could...
Read the full narrative on Constellation Energy (it's free!)
Constellation Energy’s narrative projects $38.7 billion revenue and $6.1 billion earnings by 2029. This requires 9.0% yearly revenue growth and a $2.3 billion earnings increase from $3.8 billion today.
Uncover how Constellation Energy's forecasts yield a $360.24 fair value, a 51% upside to its current price.
Exploring Other Perspectives
Some of the most optimistic analysts were already assuming revenue could reach around US$45,000,000,000 and earnings US$8,000,000,000 by 2029, which paints a far brighter picture than the baseline view that stresses nuclear aging and regulatory costs; the Walmart deal and license renewals might pull expectations toward either story, so it is worth weighing both before you decide where you stand.
Explore 9 other fair value estimates on Constellation Energy - why the stock might be worth just $292.78!
Form Your Own Verdict
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
- A great starting point for your Constellation Energy research is our analysis highlighting 4 key rewards and 2 important warning signs that could impact your investment decision.
- Our free Constellation Energy research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Constellation Energy's overall financial health at a glance.
Searching For A Fresh Perspective?
Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:
- The future of work is here. Discover the 30 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
- AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
- Invest in the nuclear renaissance through our list of 89 elite nuclear energy infrastructure plays powering the global AI revolution.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com